NATCO Pharma subsidiary launches Carboplatin in US market to address shortages

Indian pharmaceutical company NATCO Pharma annouced the launch of Carboplatin Injection, a generic version of Paraplatin in the US market by its American subsidiary. The subsidiary would collaborate in manufacturing with Chennai-based Tero Labs Pvt Ltd. The launch is aimed at meeting the shortage of the drug. Carboplatin is directed towards the treatment of advanced ovarian carcinoma, including first-line combination therapy and palliative treatment of recurrent disease after prior chemotherapy.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/rDpavA1
via IFTTT

Read More

AIIMS doctors identify ‘Red Alert Zone’ to reduce risks in complex cancer surgery

AIIMS doctors have recognized two critical anatomical zones during complex cancer surgeries in women. These zones help reduce bleeding and prevent injuries to vital organs. One zone, known as 'Ray's Zone', is crucial for surgeries involving the pelvic area. The other, 'Ray's Hepatocaval Triangle', assists during liver mobilization near major vessels. Identifying these zones enhances surgical precision and patient outcomes in oncological procedures.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/MPDFt6b
via IFTTT

Read More

The burden of cancer drugs: Millions battle exorbitant prices as life-saving treatment slips out of reach

For millions of cancer patients, the cost of treatment can be as frightening as the diagnosis. From steep markups to patented drugs that remain out of reach, the affordability crisis runs deep. A proposed cap may help, but question remains if it will be enough to change the picture.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/d2JXKVZ
via IFTTT

Read More

Aayush Wellness launches calcium, vitamin supplements; enters USD 16.3-bn bone & joint health segment

Aayush Wellness Limited has launched Aayush Calcium Vitamin Tablets, expanding its nutraceutical portfolio into the bone and joint health segment. The formulation combines calcium citrate, vitamin D2, magnesium, zinc and folic acid to support bone strength, calcium absorption and musculoskeletal health. The company said the launch aligns with growing consumer interest in preventive healthcare and nutritional supplements.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/vgTbfzQ
via IFTTT

Read More

NPPA caps trade margins on 137 cancer drugs at 30%, revised prices from Nov 9

India's National Pharmaceutical Pricing Authority has capped trade margins for 137 anti-cancer drugs at 30% of their maximum retail price. This cap, effective from November 9, applies to all listed drugs, including Atezolizumab and Bevacizumab. Manufacturers must adjust prices if they exceed the newly calculated maximum retail price. Compliance will be monitored by state drug controllers and hospitals, which play a significant role in drug supply.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/5ABuEGc
via IFTTT

Read More

Shridevi Institute, US-based Vaxonyx sign MoU for AI-driven cancer and genomic research

Shridevi Institute of Medical Sciences in Tumakuru has signed an MoU with Vaxonyx LLC for collaboration. This partnership aims to focus on AI-enabled bioinformatics and genomic research tailored for Indian populations. They will develop personalized cancer therapies by analyzing individual tumor profiles. The collaboration will also explore the creation of genomic datasets to improve genetic models. Moreover, they intend to develop DNA-based vaccine candidates for relevant public health issues.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/nj7thfi
via IFTTT

Read More

NITI Aayog explores policies to boost India's medical and dental device manufacturing industry

NITI Aayog is exploring policy measures to improve the manufacturing capabilities of medical and dental devices in India. The meeting included domestic manufacturers, government officials, and experts from IIT Delhi and IIT Mumbai. Key challenges such as regulatory hurdles and cost disadvantages faced by Indian manufacturers were discussed extensively. The industry body AiMeD emphasized the need for simpler regulations and financial support for local manufacturers.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/OU16ieb
via IFTTT

Read More